Name: preleukemia (en Inglés)
Price: 183380.00 CLP
Availability: InStock
Author: Schmalzl, F. ; Hellriegel, K. -P
ISBN: 9783540096986

Formato

Libro Físico

Ilustrado por

F. Schmalzl

K. -P Hellriegel

Editorial

Springer

Autor

Schmalzl, F. ; Hellriegel, K. -P

Año

1980

Idioma

Inglés

N° páginas

196

Encuadernación

Tapa Blanda

Dimensiones

24.4 x 17.0 x 1.1 cm

Peso

0.34 kg.

ISBN

3540096981

ISBN13

9783540096986

Categorías

Oncología

preleukemia (en Inglés)

F. Schmalzl (Ilustrado por) · K. -P Hellriegel (Ilustrado por) · Springer · Tapa Blanda

Libro Nuevo

$ 183.380

$ 254.700

Ahorras: $ 71.320

28% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Viernes 24 de Mayo y el Miércoles 05 de Junio.

Lo recibirás en cualquier lugar de Chile entre 1 y 3 días hábiles luego del envío.

Reseña del libro "preleukemia (en Inglés)"

Clinical hematologists are frequently faced with the intriguing problem of agnogenic myelo- dysplastic syndromes; these syndromes are peculiar in their failing or poor response to therapy and in that they frequently terminate in acute leukemia. An international symposium held in Innsbruck in 1978 was dedicated to clinical and pathophysiologic aspects of the preleukemic syndromes. This monograph consists of articles that correspond to the papers presented at the symposium and of the edited discussions. It was the aim of the symposium and of this monograph to outline comprehensively the pathophysiologic background of the preleukemic syndromes and to summarize the present information about their clinical management. The first part of the monograph covers that pathology of these disorders: Disturbed maturation and proliferation of the hemopoietic cells are the causes of cyto- penias, of structural and ultrastructural anomalies, and of enzymatic and functional defects. Further articles are concerned with the evaluation of these features and of chromosome anomalies as possible tools for the diagnostic and prognostic classification of myelodysplasias. Pathogenetic data and immunologic considerations form the rationale for therapeutic ap- proaches. F. Schmalzl K. -P. Hellriegel v Contents K. -P. Hellriegel and F. Schmalzl Preleukemia: Definition and Classification . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . H. Heirnpel Conventional Morphological Examination of Blood and Bone Marrow Cells in the Diagnosis of Preleukemic Syndromes . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4 C. Peschle Pure Red Cell Aplasia Type III: Progression to Acute Myeloid Leukemia and Absence of the IgG Inhibitor to Erythropoiesis . . . . . . . . . . . . . . . . . . . . . . . . . . 12 Discussion . . . . . . . . . . . . . . . . . . '. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14 . . . . I. Fohlmeister, H. E. Schaefer, K. -P. Hellriegel, and R.